e.l.f. Beauty's 36% Quarter Was Built on a Bought Brand and a Refund

This week Bloomberg put a title on e.l.f. Beauty's chief financial officer: "Chief Future Officer". Mandy Fields has held the job since 2019, and the profile points at a record that seems to back the label up. The company just reported its 30th straight quarter of growth, sales up 36%, full-year guidance raised again. On its face, the machine never stopped.

But the quarter breaks apart into pieces, and most of the pieces are not operations. That matters more than the headline, because the market read the 36% as proof that e.l.f.'s growth engine has resumed compounding. It didn't quite do that.

Start with the revenue. The 36% growth includes a brand e.l.f. bought rather than built. Hailey Bieber's Rhode, acquired in May for $1 billion, contributed about $160 million of the quarter's $479 million in sales — roughly a third. Strip Rhode out and e.l.f.'s organic net sales fell in the high single digits against a busy year-ago period, with organic unit volumes down roughly 3%. The thing e.l.f. is famous for — pricing cult makeup low enough that ordinary people buy it in volume — slowed down. The acceleration was purchased.

Now the part that made the quarter look like a triumph: gross margin rose about 14 percentage points, to 83%. That reads as a step-change in pricing power. It wasn't. About ten and a half of those points came from a one-time $50 million refund of IEEPA tariffs, the duties the Supreme Court struck down. Exclude the refund and gross margin improved about three and a half points — real, but not a paradigm shift. Net income nearly doubled in part because of a court ruling, not because customers reordered faster. The refund alone added roughly $0.68 to adjusted earnings per share.

The growth e.l.f. did buy also cost real money. The Rhode deal was structured as $600 million in cash, $200 million in e.l.f. stock, and $200 million in earnouts. Total debt went from about $257 million to $834 million in a year, and goodwill roughly doubled to $853 million. Management now guides to only 6% to 7% organic growth for the full fiscal year — the celebrated 18% to 20% top-line number relies on Rhode adding about 13 points.

None of that makes the acquisition fake or failing. Rhode looks genuinely strong: it's on pace for roughly $300 million in sales this year, it's expanding into Sephora across Europe, and it has outperformed the milestones that trigger the earnout — which is why e.l.f. had to book a charge against the deal's fair value. The tariff money is real cash management says it will reinvest in marketing and price cuts. International is still only about a fifth of sales. There is real substance here.

The discipline is in reading the headline correctly. The celebrated quarter was an optical triumph: a third of the growth bought for $1 billion, the margin blowout from a one-time refund, and a cooling core underneath. None of it is deceptive on its own. All of it affects what the stock is priced to do.

Here's the test that sorts it out. Two disclosed numbers matter going forward: organic unit volume — not total revenue, which now runs through Rhode — and gross margin excluding the refund. If core volumes turn back up and ex-refund margin holds near that low-70s level, the multiple the market pays, roughly 27 times the $3.50 to $3.55 in adjusted earnings per share the company just guided to, becomes more defensible for a business with real, self-built growth. If core volumes stay soft and the margin steps back down once the check clears, then much of the "future" in the profile was purchased or refunded, and the patience built into that multiple is the whole bet.

The stock is up more than a quarter this year because the market took the 36% at face value. The organic number says otherwise, and it's sitting right there in the disclosure. Watch the sub-number, not the celebration.